• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白甲基转移酶 SETD6 通过对 PLK1 的甲基化调控有丝分裂进程。

The methyltransferase SETD6 regulates Mitotic progression through PLK1 methylation.

机构信息

The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105 Be'er-Sheva, Israel;

The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, 84105 Be'er-Sheva, Israel.

出版信息

Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1235-1240. doi: 10.1073/pnas.1804407116. Epub 2019 Jan 8.

DOI:10.1073/pnas.1804407116
PMID:30622182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6347700/
Abstract

Lysine methylation, catalyzed by protein lysine methyltransferases (PKMTs), is a key player in regulating intracellular signaling pathways. However, the role of PKMTs and the methylation of nonhistone proteins during the cell cycle are largely unexplored. In a recent proteomic screen, we identified that the PKMT SETD6 methylates PLK1-a key regulator of mitosis and highly expressed in tumor cells. In this study, we provide evidence that SETD6 is involved in cell cycle regulation. SETD6-deficient cells were observed to progress faster through the different mitotic steps toward the cytokinesis stage. Mechanistically, we found that during mitosis SETD6 binds and methylates PLK1 on two lysine residues: K209 and K413. Lack of methylation of these two residues results in increased kinase activity of PLK1, leading to accelerated mitosis and faster cellular proliferation, similarly to SETD6-deficient cells. Taken together, our findings reveal a role for SETD6 in regulating mitotic progression, suggesting a pathway through which SETD6 methylation activity contributes to normal mitotic pace.

摘要

赖氨酸甲基化,由蛋白赖氨酸甲基转移酶(PKMTs)催化,是调节细胞内信号通路的关键因素。然而,PKMTs 的作用以及细胞周期中非组蛋白的甲基化在很大程度上尚未被探索。在最近的蛋白质组学筛选中,我们发现 PKMT SETD6 甲基化 PLK1-有丝分裂的关键调节因子,在肿瘤细胞中高度表达。在这项研究中,我们提供了 SETD6 参与细胞周期调控的证据。观察到 SETD6 缺陷细胞在有丝分裂的不同阶段更快地向胞质分裂阶段前进。从机制上讲,我们发现,在有丝分裂期间,SETD6 结合并甲基化 PLK1 的两个赖氨酸残基:K209 和 K413。这两个残基的甲基化缺失导致 PLK1 的激酶活性增加,从而加速有丝分裂和更快的细胞增殖,与 SETD6 缺陷细胞相似。总之,我们的发现揭示了 SETD6 在调节有丝分裂进程中的作用,提示 SETD6 甲基化活性有助于正常有丝分裂速度的途径。

相似文献

1
The methyltransferase SETD6 regulates Mitotic progression through PLK1 methylation.组蛋白甲基转移酶 SETD6 通过对 PLK1 的甲基化调控有丝分裂进程。
Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1235-1240. doi: 10.1073/pnas.1804407116. Epub 2019 Jan 8.
2
A PIM-CHK1 signaling pathway regulates PLK1 phosphorylation and function during mitosis.一个 PIM-CHK1 信号通路在有丝分裂过程中调节 PLK1 的磷酸化和功能。
J Cell Sci. 2018 Aug 10;131(15):jcs213116. doi: 10.1242/jcs.213116.
3
Playing polo during mitosis: PLK1 takes the lead.有丝分裂期间打马球:PLK1 起带头作用。
Oncogene. 2017 Aug 24;36(34):4819-4827. doi: 10.1038/onc.2017.113. Epub 2017 Apr 24.
4
Oligomerization and Auto-methylation of the Human Lysine Methyltransferase SETD6.人赖氨酸甲基转移酶 SETD6 的寡聚化和自身甲基化。
J Mol Biol. 2018 Oct 19;430(21):4359-4368. doi: 10.1016/j.jmb.2018.08.028. Epub 2018 Sep 4.
5
P21-activated kinase is required for mitotic progression and regulates Plk1.P21激活激酶是有丝分裂进程所必需的,并调节Plk1。
Oncogene. 2008 Aug 21;27(36):4900-8. doi: 10.1038/onc.2008.131. Epub 2008 Apr 21.
6
PAK4 Methylation by SETD6 Promotes the Activation of the Wnt/β-Catenin Pathway.SETD6介导的PAK4甲基化促进Wnt/β-连环蛋白信号通路的激活。
J Biol Chem. 2016 Mar 25;291(13):6786-95. doi: 10.1074/jbc.M115.697292. Epub 2016 Feb 3.
7
Polo-like kinase 1 reaches beyond mitosis--cytokinesis, DNA damage response, and development.Polo样激酶1的作用超出有丝分裂范畴——涉及胞质分裂、DNA损伤反应及发育过程。
Curr Opin Cell Biol. 2008 Dec;20(6):650-60. doi: 10.1016/j.ceb.2008.10.005. Epub 2008 Nov 27.
8
Regulating a key mitotic regulator, polo-like kinase 1 (PLK1).调控关键的有丝分裂调节因子,即波罗样激酶1(PLK1)。
Cytoskeleton (Hoboken). 2018 Nov;75(11):481-494. doi: 10.1002/cm.21504. Epub 2018 Dec 7.
9
14-3-3zeta cooperates with phosphorylated Plk1 and is required for correct cytokinesis.14-3-3ζ与磷酸化的Plk1协同作用,是正确的胞质分裂所必需的。
Front Biosci (Schol Ed). 2012 Jan 1;4(2):639-50. doi: 10.2741/s290.
10
Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1.有丝分裂和胞质分裂过程中Plk1对接伴侣的选择受Cdk1激活状态的控制。
Nat Cell Biol. 2007 Apr;9(4):436-44. doi: 10.1038/ncb1557. Epub 2007 Mar 11.

引用本文的文献

1
RAD18 methylation by the methyltransferase SETD6 attenuates DNA breaks.甲基转移酶SETD6介导的RAD18甲基化可减轻DNA断裂。
Sci Rep. 2025 Aug 27;15(1):31643. doi: 10.1038/s41598-025-16908-3.
2
SETD6 mediates selective interaction and genomic occupancy of BRD4 and MITF in melanoma cells.SET结构域蛋白6(SETD6)介导黑素瘤细胞中BRD4与小眼畸形相关转录因子(MITF)的选择性相互作用及基因组占位。
NAR Cancer. 2025 Aug 7;7(3):zcaf023. doi: 10.1093/narcan/zcaf023. eCollection 2025 Sep.
3
Orchestrating epigenetics: a comprehensive review of the methyltransferase SETD6.调控表观遗传学:甲基转移酶SETD6的全面综述
Exp Mol Med. 2025 Mar;57(3):533-544. doi: 10.1038/s12276-025-01423-2. Epub 2025 Mar 18.
4
KDM5D histone demethylase mediates p38α inactivation via its enzymatic activity to inhibit cancer progression.KDM5D组蛋白去甲基化酶通过其酶活性介导p38α失活,从而抑制癌症进展。
Proc Natl Acad Sci U S A. 2024 Dec 10;121(50):e2402022121. doi: 10.1073/pnas.2402022121. Epub 2024 Dec 5.
5
Methylation of ESCRT-III components regulates the timing of cytokinetic abscission.ESCRT-III 组件的甲基化调节胞质分裂的分离时间。
Nat Commun. 2024 May 13;15(1):4023. doi: 10.1038/s41467-024-47717-3.
6
Distinct specificities of the HEMK2 protein methyltransferase in methylation of glutamine and lysine residues.HEMK2 蛋白甲基转移酶在谷氨酰胺和赖氨酸残基甲基化中的独特特异性。
Protein Sci. 2024 Feb;33(2):e4897. doi: 10.1002/pro.4897.
7
Polo-like kinase 1 (PLK1) O-GlcNAcylation is essential for dividing mammalian cells and inhibits uterine carcinoma.丝氨酸苏氨酸激酶 1(PLK1)O-连接的 N-乙酰葡萄糖胺化对于有丝分裂的哺乳动物细胞是必需的,并能抑制子宫癌。
J Biol Chem. 2023 Feb;299(2):102887. doi: 10.1016/j.jbc.2023.102887. Epub 2023 Jan 7.
8
Investigating the functional role of SETD6 in lung adenocarcinoma.探究 SETD6 在肺腺癌中的功能作用。
BMC Cancer. 2023 Jan 6;23(1):18. doi: 10.1186/s12885-022-10476-9.
9
Unmasking the mammalian SET domain-containing protein 4.揭示含SET结构域的哺乳动物蛋白4
NAR Cancer. 2022 Jul 13;4(3):zcac021. doi: 10.1093/narcan/zcac021. eCollection 2022 Sep.
10
SETD4-mediated KU70 methylation suppresses apoptosis.SETD4 通过介导 KU70 甲基化抑制细胞凋亡。
Cell Rep. 2022 May 10;39(6):110794. doi: 10.1016/j.celrep.2022.110794.

本文引用的文献

1
SUMOylation Promotes Nuclear Import and Stabilization of Polo-like Kinase 1 to Support Its Mitotic Function.SUMOylation 促进 Polo 样激酶 1 的核输入和稳定,以支持其有丝分裂功能。
Cell Rep. 2017 Nov 21;21(8):2147-2159. doi: 10.1016/j.celrep.2017.10.085.
2
Cyclin A/Cdk1 modulates Plk1 activity in prometaphase to regulate kinetochore-microtubule attachment stability.周期蛋白 A/细胞周期蛋白依赖性激酶 1 在前期调节着 Plk1 的活性,以调节着动粒-微管的附着稳定性。
Elife. 2017 Nov 20;6:e29303. doi: 10.7554/eLife.29303.
3
The winding path of protein methylation research: milestones and new frontiers.蛋白质甲基化研究的曲折道路:里程碑和新前沿。
Nat Rev Mol Cell Biol. 2017 Aug;18(8):517-527. doi: 10.1038/nrm.2017.35. Epub 2017 May 17.
4
SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer.SETD6调节尿路上皮细胞存活中的NF-κB信号通路:对膀胱癌的影响。
Oncotarget. 2017 Feb 28;8(9):15114-15125. doi: 10.18632/oncotarget.14750.
5
Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics.Plk1抑制剂在癌症治疗中的应用:从实验室到临床
Mol Cancer Ther. 2016 Jul;15(7):1427-35. doi: 10.1158/1535-7163.MCT-15-0897. Epub 2016 Jun 21.
6
Molecular dynamics of PLK1 during mitosis.有丝分裂过程中PLK1的分子动力学
Mol Cell Oncol. 2014 Oct 29;1(2):e954507. doi: 10.1080/23723548.2014.954507. eCollection 2014 Apr-Jun.
7
PAK4 Methylation by SETD6 Promotes the Activation of the Wnt/β-Catenin Pathway.SETD6介导的PAK4甲基化促进Wnt/β-连环蛋白信号通路的激活。
J Biol Chem. 2016 Mar 25;291(13):6786-95. doi: 10.1074/jbc.M115.697292. Epub 2016 Feb 3.
8
SETD6 is a negative regulator of oxidative stress response.SET结构域蛋白6是氧化应激反应的负调节因子。
Biochim Biophys Acta. 2016 Feb;1859(2):420-7. doi: 10.1016/j.bbagrm.2016.01.003. Epub 2016 Jan 15.
9
Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment.靶向波罗样激酶:一种有前景的癌症治疗方法。
Transl Oncol. 2015 Jun;8(3):185-95. doi: 10.1016/j.tranon.2015.03.010.
10
Mammalian Polo-like kinase 1 (Plk1) promotes proper chromosome segregation by phosphorylating and delocalizing the PBIP1·CENP-Q complex from kinetochores.哺乳动物的Polo样激酶1(Plk1)通过磷酸化PBIP1·CENP-Q复合物并使其从动粒上脱离定位,来促进染色体的正确分离。
J Biol Chem. 2015 Mar 27;290(13):8569-81. doi: 10.1074/jbc.M114.623546. Epub 2015 Feb 10.